SMITH ALAN E

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Alan E. Smith
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by SMITH ALAN E:

Company Role Class Num Shares Value Price $ Report Date Ownership
Candel Therapeutics, Inc. Director Common Stock 32,548 $29,293 $0.9000 26 Jul 2021 Direct

Insider Reports Filed by SMITH ALAN E

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CADL Candel Therapeutics, Inc. 26 Jul 2021 0 $0 3 Director 26 Jul 2021, 21:24